Perrigo (PRGO) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs
May 31, 2017 5:12 AM EDTGoldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.
Analyst Jami Rubin writes to clients in a late Tuesday note that RX prices have eroded 11-13 percent compared with company guidance of 9-11 percent for FY 2017.
"...we calculate... More
Perrigo (PRGO) Files Form 10-Q; Reports Q1 Results
May 30, 2017 5:17 PM EDTDelivered first quarter 2017 GAAP ("reported") net sales of $1.2 billion, led by consumer-facing businesses net sales of $958 millionRealized first quarter reported net income of $72 million and reported earnings per share ("EPS") of $0.50Achieved adjusted net income of $150 million and adjusted diluted EPS of $1.05First quarter cash flow from operations was $195 million; cash flow from operations of 272% as a percentage to net income and 130% as a percentage to adjusted net income CHCI profit improvement plan yielding positive results... More
